Research News

Researchers have now identified that absence of a brain chemical can lead to hyperactivity and sleeplessness. The findings were found in the Neuron. These findings could help researchers to develop new drugs that promote better sleep, or control hyperactivity in people with the medical condition mania.

A new drug, called PF-04449913, which was found promising for treating blood cancer is now in phase II clinical trials. The study appeared online in the The Lancet Hematology.

A new study says using omega-3 fatty acids in anti-tumor medications may improve treatment response and quality of life for cancer patients.  This study published in Journal of Parenteral and Enteral Nutrition.

A new therapy discovered that cuts off the way some cancer cells communicate significantly and slows the rapid spread of a common and deadly brain tumor. The study was published in Cell Reports.

Breast cancer survivors are especially vulnerable to dyspareunia, or painful sexual intercourse, because their treatment mainly focuses on eradicating the sex hormone estrogen. A new research has suggested that application of liquid lidocaine, a common local anesthetic, may significantly improve sexual function of breast cancer survivors who experience pain during sexual intercourse. The research appeared online in the Journal of Clinical Oncology.

Medical researchers have claimed that men who experience erectile dysfunction might face twice the risk of Type 2 Diabetes compared to men without such sexual incapability. The story is published in Annals of Family Medicine.

Arsenic, which can be present in ground water, modifies an enzyme that alters the secretion of insulin in the pancreas. Physicians, usually, show type II diabetes as a consequence of an exaggerated food intake and lack of exercise.

[adsense:336x280:8701650588]

Which plays a crucial role in malaria infection, and may lead to potential new drug to fight the disease. The study is published in Journal of Experimental Medicine.